RETRACTED ARTICLE: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
Abstract Background Hepatocellular carcinoma (HCC) remains difficult to cure due to lack of effective treatment and the molecular mechanisms are complex and not completely understood. In this study, We investigated the role of CDK16 in tumor progression of HCC. Methods We interrogated the expression...
Main Authors: | Yitao Wang, Xian Qin, Tao Guo, Pengpeng Liu, Ping Wu, Zhisu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-017-0569-2 |
Similar Items
-
MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma
by: Huiming Zhang, et al.
Published: (2021-01-01) -
Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma
by: Li S, et al.
Published: (2019-07-01) -
Knockdown of MUC16 (CA125) Enhances the Migration and Invasion of Hepatocellular Carcinoma Cells
by: Yao Huang, et al.
Published: (2021-06-01) -
Metformin induces miR-378 to downregulate the CDK1, leading to suppression of cell proliferation in hepatocellular carcinoma
by: Zhou J, et al.
Published: (2018-07-01) -
Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
by: Maha Elazezy, et al.
Published: (2021-07-01)